Janssen COVID-19 Vaccine

DB15857

biotech approved investigational

Deskripsi

The Janssen COVID-19 vaccine (Ad26.COV2.S) is a recombinant vaccine that contains an adenovirus serotype 26 (Ad26) vector expressing a stabilized SARS-CoV-2 spike protein. The vaccine was created in collaboration with Johnson and Johnson (J&J), Janssen Pharmaceutical, and the Beth Israel Deaconess Medical Center. A preclinical study in hamsters infected with SARS-COV-2 infectionA220053 showed a single immunization with the vaccine-elicited neutralizing responses and protected against SARS-CoV-2 induced pneumonia and mortality, providing protection against the disease progression. Follow-up preclinical studies in rhesus monkeysA220058 showed that the Ad26 vaccine produced a robust response and provided near perfect protection in nasal swabs and bronchoalveolar lavage following SARS-COV-2 challenge. As of June 2020, a Phase 1/2 clinical trial in adult humans was announced to evaluate the safety, immunogenicity, and efficacy of the ad26.COV.S vaccine in 1045 healthy adults between the ages of 18-55 (NCT04436276). The Janssen COVID-19 vaccine is available under an Emergency Use Authorization (EUA) in the US.L41745

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

285 Data
Etanercept The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Etanercept.
Peginterferon alfa-2a The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Peginterferon alfa-2a.
Interferon alfa-n1 The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-n1.
Interferon alfa-n3 The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-n3.
Peginterferon alfa-2b The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Peginterferon alfa-2b.
Anakinra The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Anakinra.
Interferon gamma-1b The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon gamma-1b.
Interferon alfa-2a The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-2a.
Aldesleukin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Aldesleukin.
Adalimumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Adalimumab.
Gemtuzumab ozogamicin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Gemtuzumab ozogamicin.
Pegaspargase The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pegaspargase.
Infliximab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Infliximab.
Interferon beta-1b The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon beta-1b.
Interferon alfacon-1 The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfacon-1.
Trastuzumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Trastuzumab.
Rituximab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Rituximab.
Basiliximab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Basiliximab.
Muromonab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Muromonab.
Ibritumomab tiuxetan The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ibritumomab tiuxetan.
Tositumomab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tositumomab.
Alemtuzumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Alemtuzumab.
Cyclosporine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cyclosporine.
Alefacept The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Alefacept.
Efalizumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Efalizumab.
Antithymocyte immunoglobulin (rabbit) The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Interferon alfa-2b The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-2b.
Natalizumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Natalizumab.
Daclizumab The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Daclizumab.
Phenylalanine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Phenylalanine.
Flunisolide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Flunisolide.
Bortezomib The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bortezomib.
Cladribine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cladribine.
Carmustine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carmustine.
Amsacrine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Amsacrine.
Bleomycin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bleomycin.
Chlorambucil The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Chlorambucil.
Raltitrexed The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Raltitrexed.
Mitomycin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mitomycin.
Bexarotene The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bexarotene.
Vindesine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vindesine.
Floxuridine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Floxuridine.
Fluorometholone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluorometholone.
Indomethacin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Indomethacin.
Tioguanine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tioguanine.
Vinorelbine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vinorelbine.
Dexrazoxane The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dexrazoxane.
Beclomethasone dipropionate The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Beclomethasone dipropionate.
Sorafenib The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sorafenib.
Streptozocin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Streptozocin.
Trifluridine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Trifluridine.
Gemcitabine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Gemcitabine.
Betamethasone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Betamethasone.
Teniposide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Teniposide.
Epirubicin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Epirubicin.
Chloramphenicol The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Chloramphenicol.
Lenalidomide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Lenalidomide.
Altretamine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Altretamine.
Zidovudine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Zidovudine.
Cisplatin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cisplatin.
Oxaliplatin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Oxaliplatin.
Cyclophosphamide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cyclophosphamide.
Vincristine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vincristine.
Fluorouracil The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluorouracil.
Desoximetasone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Desoximetasone.
Propylthiouracil The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Propylthiouracil.
Pentostatin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pentostatin.
Methotrexate The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Methotrexate.
Carbamazepine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carbamazepine.
Vinblastine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vinblastine.
Fluticasone propionate The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluticasone propionate.
Fluocinolone acetonide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluocinolone acetonide.
Linezolid The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Linezolid.
Imatinib The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Imatinib.
Triamcinolone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Triamcinolone.
Clofarabine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Clofarabine.
Prednisone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Prednisone.
Pemetrexed The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pemetrexed.
Flumethasone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Flumethasone.
Fludrocortisone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fludrocortisone.
Mycophenolate mofetil The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mycophenolate mofetil.
Daunorubicin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Daunorubicin.
Hydrocortisone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Hydrocortisone.
Irinotecan The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Irinotecan.
Methimazole The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Methimazole.
Mometasone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mometasone.
Etoposide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Etoposide.
Sulfasalazine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sulfasalazine.
Dacarbazine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dacarbazine.
Temozolomide The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Temozolomide.
Penicillamine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Penicillamine.
Prednisolone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Prednisolone.
Tacrolimus The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tacrolimus.
Sirolimus The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sirolimus.
Mechlorethamine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mechlorethamine.
Azacitidine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Azacitidine.
Carboplatin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carboplatin.
Methylprednisolone The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Methylprednisolone.
Dactinomycin The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dactinomycin.
Azathioprine The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Azathioprine.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 32884153
    Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE, Nekorchuk M, Busman-Sahay K, Piedra-Mora C, Wrijil LM, Ducat S, Custers J, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Lin Z, Mahrokhian SH, Nampanya F, Nityanandam R, Pessaint L, Porto M, Ali V, Benetiene D, Tevi K, Andersen H, Lewis MG, Schmidt AG, Lauffenburger DA, Alter G, Estes JD, Schuitemaker H, Zahn R, Barouch DH: Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 Sep 3. pii: 10.1038/s41591-020-1070-6. doi: 10.1038/s41591-020-1070-6.
  • PMID: 32731257
    Mercado NB, Zahn R, Wegmann F, Loos C, Chandrashekar A, Yu J, Liu J, Peter L, McMahan K, Tostanoski LH, He X, Martinez DR, Rutten L, Bos R, van Manen D, Vellinga J, Custers J, Langedijk JP, Kwaks T, Bakkers MJG, Zuijdgeest D, Rosendahl Huber SK, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Hoffman E, Jacob-Dolan C, Kirilova M, Li Z, Lin Z, Mahrokhian SH, Maxfield LF, Nampanya F, Nityanandam R, Nkolola JP, Patel S, Ventura JD, Verrington K, Wan H, Pessaint L, Van Ry A, Blade K, Strasbaugh A, Cabus M, Brown R, Cook A, Zouantchangadou S, Teow E, Andersen H, Lewis MG, Cai Y, Chen B, Schmidt AG, Reeves RK, Baric RS, Lauffenburger DA, Alter G, Stoffels P, Mammen M, Van Hoof J, Schuitemaker H, Barouch DH: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 Jul 30. pii: 10.1038/s41586-020-2607-z. doi: 10.1038/s41586-020-2607-z.

Contoh Produk & Brand

Produk: 4 • International brands: 0
Produk
  • Covid-19 Vaccine Janssen
    Injection, suspension • 8.92 log₁₀ Inf. U • Intramuscular • EU
  • Covid-19 Vaccine Janssen
    Injection, suspension • 8.92 log₁₀ Inf. U • Intramuscular • EU
  • Janssen COVID-19 Vaccine
    Injection, suspension • 50000000000 {VP}/0.5mL • Intramuscular • US
  • Jcovden
    Suspension • 50000000000 vp / 0.5 mL • Intramuscular • Canada • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul